142P Bone mineral density (BMD) after three years of adjuvant zoledronic acid (ZA) in postmenopausal oestrogen receptor positive (ER+) early breast cancer (EBC): An observational single centre study. - Harper-Wynne, C.; Burcombe, R. (Annals of Oncology, 2021)